Loading organizations...
§ Private Profile · Vitacura, Region Metropolitana, Chile
Biotech company producing advanced botanical compounds for agriculture and pharmaceuticals, using sustainable plant tissue culture.
Botanical Solution Inc. is a Davis, California-based biotechnology company that utilizes proprietary plant tissue culture technology to manufacture advanced botanical materials for the agriculture and pharmaceutical sectors. The organization cultivates plants such as Quillaja saponaria within laboratory bioreactors to extract active ingredients for biofungicides and vaccine adjuvants without natural harvesting. Its primary products include the agricultural biofungicide Quillibrium and QS-21, an adjuvant utilized in vaccines approved by the FDA for shingles, malaria, RSV, and COVID. The venture-backed enterprise has raised approximately $10 million in funding as of 2022 and generates revenue through product sales and licensing agreements with major agrochemical partners like Syngenta. The firm won a Best Startup Company award from the World Bioprotection Forum following its expansion into pharmaceutical applications. The company was founded in 2013 by Gastón Salinas and Gustavo Zúñiga.
Botanical Solutions has raised $24.0M across 4 funding rounds.
Botanical Solutions has raised $24.0M in total across 4 funding rounds.
Botanical Solutions has raised $24.0M across 4 funding rounds. Most recently, it raised $7.6M Series A in August 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 20, 2024 | $7.6M Series A | — | — | Announced |
| Aug 23, 2023 | $7M Series A | — | — | Announced |
| Jan 17, 2022 | $6.1M Series A | Otter Capital | — | Announced |
| Dec 23, 2020 | $3.3M Seed | — | — | Announced |
Botanical Solutions has raised $24.0M in total across 4 funding rounds.
Botanical Solutions's investors include Otter Capital.